Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EBS Net Margin

The Net Margin of Emergent BioSolutions Inc. (EBS) is 7.08%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

EBS Net Margin - Historical Value
Date Value
2025-12-31 7.08%
2024-12-31 -18.26%
2023-12-31 -72.48%
2022-12-31 -18.88%
2021-12-31 12.24%
2020-12-31 19.62%
2019-12-31 4.93%
2018-12-31 8.01%
2017-12-31 14.73%
2016-12-31 10.60%
EBS Net Margin - Peers Comparison